Rehabilitation Hospital of Indiana
Indianapolis, Indiana, 46254, United States
NCT Number: NCT05720013
The purpose of this study is to investigate if a beetroot juice supplement can improve oxygen capacity during walking tasks at a submaximal and maximal effort in people greater than 6 months following stroke.
Looking for future studies?
Notify Me18 year–89 year
All sexes
Interventional
Not applicable
Indianapolis, Indiana, 46254, United States
During this study, participants will perform baseline measurements such as walking and balance tests. During baseline testing, participants will be asked to perform a maximal exertion test while walking on a treadmill to determine the speed for a submaximal walking test. One week after baseline testing, the participant will have an intervention session where they drink either a beetroot juice supplement or a placebo. The placebo will taste similar to the beetroot juice and participants may not be able to tell the difference between the two different supplements. After a week, the participant will return to the lab and drink the other supplement. For example, if the participant drank the beetroot juice in the first session, then they will drink the placebo in the second session. During each intervention session, the participant will be asked to perform two treadmill tests, one with submaximal effort and one with maximal effort. After the walking tests, they will drink either the beetroot juice or placebo and have their blood drawn. They will wait at the hospital for 2-3 hours and have their blood drawn again. The participants will then complete the two treadmill tests again. The two intervention sessions will last about 4-6 hours for each session. Participation in the study will last 4-6 weeks including screening and baseline testing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The experimental arm includes orally ingesting 140 mL Beet-It Sport Nitrate 400.
he placebo arm involves orally ingesting a 140 mL placebo solution with the dietary nitrate removed.
Other names: Placebo Beetroot Juice supplement
Time frame: Measures assessed prior to and following 2-3 hours after beetroot juice or placebo ingestion
Oxygen Consumption during steady state walking prior to and following placebo or beetroot juice ingestion
Time frame: Measures assessed prior to and following 2-3 hours after beetroot juice or placebo ingestion
Blood samples taken prior and following ingestion of either the beetroot juice or placebo supplements.
Time frame: Measures assessed prior to and following 2-3 hours after beetroot juice or placebo ingestion
Fastest speed achieved for one minute on the treadmill during the graded treadmill test performed prior to and following placebo or beetroot juice ingestion.
Time frame: Measures assessed prior to and following 2-3 hours after beetroot juice or placebo ingestion.
Oxygen Consumption during maximal exertion walking during the graded treadmill test prior to and following placebo or beetroot juice ingestion
Time frame: Measures assessed prior to and following 2-3 hours after beetroot juice or placebo ingestion.
Peak heart rate during maximal exertion walking on the graded treadmill test prior to and following placebo or beetroot juice ingestion
Indiana University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05196737
Brain Diseases, CVA
Charleston, South Carolina, United States
View Trial DetailsNCT02207023
Apoplexy, Brain Diseases
New Westminster, British Columbia, Canada
View Trial DetailsNCT02693834
Brain Diseases, CVA
Frisco, Texas, United States
View Trial DetailsNCT00792428
Acute Cerebrovascular Accident, Acute Stroke
Boston, Massachusetts, United States
View Trial Details